Vulval disorders (lichen sclerosus)
Vulval · Gynaecology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Lichen sclerosus is a chronic inflammatory skin condition causing vulval itch, soreness and architectural change, with a small risk of vulval squamous cell carcinoma. Potent topical steroids control symptoms and reduce scarring.
Red flags
- Persistent ulcer, lump or non-healing lesion
- Thickened or raised areas despite treatment
- Bleeding from vulval skin
- Rapid change in a known lesion
- Lesion not responding to adequate steroid
Assessment
Differential diagnosis
- Lichen sclerosus
- Lichen planus
- Vulval eczema/dermatitis
- Vulvovaginal candidiasis
- Vulval intraepithelial neoplasia
- Vulval carcinoma
Investigations
- Clinical examination of the vulva (white atrophic plaques, figure-of-eight pattern, architectural loss)
- Vulval biopsy if diagnosis uncertain, atypical, or not responding to treatment
- Swabs to exclude superimposed infection
- Assessment for associated autoimmune disease (e.g. thyroid)
- Photographic or diagrammatic documentation for monitoring
Management
- Take a history of itch, soreness, dyspareunia and skin change
- Examine the vulva for characteristic features and architectural change
- Biopsy if there is diagnostic doubt, atypical features, or a non-healing lesion
- Start a potent/ultrapotent topical corticosteroid as first-line treatment
- Use a reducing regimen and then maintenance to control disease
- Advise emollient soap substitutes and avoidance of irritants
- Educate on the small risk of vulval cancer and the need to report new lumps, ulcers or non-healing areas
- Arrange follow-up to assess response and monitor for malignant change
- Refer persistent, atypical or suspicious lesions for biopsy and possible oncology input
Drugs & doses
Clobetasol propionate 0.05% ointment once daily reducing to maintenance (e.g. once to twice weekly)
Emollient/soap substitute regularly
Topical calcineurin inhibitors (tacrolimus) as second-line
Treat superimposed candida with topical or oral antifungal if present
Disposition
Primary or secondary care management with topical steroids; refer to vulval clinic or dermatology for diagnostic uncertainty, and urgently to gynaecological oncology for suspicious lesions.
Complications & pitfalls
- Vulval squamous cell carcinoma
- Scarring and loss of vulval architecture (burying of clitoris, introital narrowing)
- Dyspareunia
- Secondary infection
- Psychological and sexual impact
Exam pearls
- Ultrapotent topical steroids are safe and effective; undertreatment causes more harm than steroid use
- Any non-healing or atypical vulval lesion needs biopsy to exclude cancer
- Maintenance steroid reduces flares and scarring
- Lichen sclerosus is associated with other autoimmune conditions
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.